RRML - MMP-2 and MMP-9 gene polymorphisms and risk of head and neck carcinomas
AMLR

ISSN online: 2284-5623

ISSN-L: 1841-6624

Rejection rate (2020): 75%

Română English

Journal Metrics

Impact Factor 0.5
Five Year Impact Factor 0.5
JCI 0.12

Advanced search

Top 10 downloaded articles
- June 2025 -
 
Romanian Review of Laboratory ... 19
Neutrophil extracellular traps... 14
The EAS-EFLM consensus on the ... 14
Implementing essential require... 13
Pilot study on laboratory samp... 13
Investigation of cytokine chan... 12
Correlations of vascular cogni... 12
Incidence rate of postoperativ... 11
Value of serum NT-IGFBP-4 for ... 10
Towards appropriate training f... 9

Log in

Concept, Design & Programming
Dr. Adrian Man
   
 
Nr. 30(2)/2022 DOI:10.2478/rrlm-2022-0010
XML
TXT

Research article

MMP-2 and MMP-9 gene polymorphisms and risk of head and neck carcinomas

Sorina Schipor, Adina Zamfir, Dan Cristian Gheorghe, Catalina Picu, Dana Manda

Correspondence should be addressed to: Sorina Schipor

Abstract:

Background: Head and neck carcinomas (HNC) account for a majority of ear, nose and throat tumours. They account for 6.3% of all incident malignancies and 6.2 % of all deaths from cancer in Romania in 2020, the fifth most common cancer in this Eastern Europe country. Aim of the study: The aim of our study was to investigate the association between two MMP-2 and MMP-9 promoter gene polymorphisms and head and neck cancer. Methods. We enrolled 142 subjects, 65 cancer patients, and 77 control subjects and tested them for MMP-2 -735 C/T and MMP-9 -1562 C/T polymorphisms by PCR-RFLP. Results. Comparison between cancer patients and controls demonstrated the presence of MMP-2 -735 C/T and MMP-9 -1562 C/T in head and neck malignant tumours, with OR = 2.206 (95% CI 1.058-4.599, P = 0.03) for MMP-2 and OR = 2.748 (95% C.I. 1.262-5.981, P=0.009) for MMP-9 gene polymorphism. This means that the presence of T allele could be a risk factor for head and neck cancer development. The analysis included a stratification of studied groups by age and gender. Conclusions. Both genotypes were associated with a significant risk for head and neck carcinomas in case of the presence of the T allele. MMP-2 -735 C/T (rs2285053) and MMP-9 -1562 C/T (rs3918242) gene polymorphism could be an important genetic marker for head and neck cancer susceptibility. This finding could be useful for genetic screening in head and neck carcinomas.

Keywords: risk, polymorphism, MMP-9, MMP-2, head and neck squamous cell carcinomas

Received: 10.6.2021
Accepted: 28.1.2022
Published: 11.2.2022

 
  PDF Download full text PDF
(521 KB)
     
 
How to cite
Schipor S, Zamfir A, Gheorghe DC, Picu C, Manda D. MMP-2 and MMP-9 gene polymorphisms and risk of head and neck carcinomas. Rev Romana Med Lab. 2022;30(2):163-71. DOI:10.2478/rrlm-2022-0010